Kenneth Reed

Kenneth Reed MD is a board certified dermatologist in private practice. After completing residency at the Harvard-MGH combined dermatology program, he established a clinical practice in a Boston suburb, created DermAsap, and has continued as a clinical investigator for a number of biotechnology and pharmaceutical companies. He currently serves on the board of directors of Red Hill Biopharma, and has served on various scientific advisory boards to a number of pharmaceutical and medical technology companies. Dr. Reed is also a cofounder of Early Cell, a company focused on early detection of circulating fetal cells, and Prescient Pharma which focuses on cellular rejuvenation.